Learn About Seborrheic Keratosis

What is the definition of Seborrheic Keratosis?

Seborrheic keratosis is a condition that causes wart-like growths on the skin. The growths are noncancerous (benign).

What are the alternative names for Seborrheic Keratosis?

Benign skin tumors - keratosis; Keratosis - seborrheic; Senile keratosis; Senile verruca

What are the causes of Seborrheic Keratosis?

A seborrheic keratosis is a benign form of skin tumor. The cause is unknown.

The condition commonly appears after age 40. It tends to run in families.

What are the symptoms of Seborrheic Keratosis?

Symptoms of seborrheic keratosis are skin growths that:

  • Are located on the face, chest, shoulders, back, or other areas, except the lips, palms, and soles
  • Are painless, but may become irritated and itchy
  • Are most often tan, brown, or black
  • Have a slightly raised, flat surface
  • May have a rough texture (like a wart)
  • Often have a waxy surface
  • Are round or oval
  • May look like a piece of bee's wax that has been "pasted-on" the skin
  • Often appear in clusters
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Seborrheic Keratosis?

You generally do not need treatment unless growths get irritated or affect your appearance.

Growths may be removed with surgery or freezing (cryotherapy).

Who are the top Seborrheic Keratosis Local Doctors?

Mercy Health System Corporation

N2950 State Rd, Suite 67, 
Lake Geneva, WI 
 5.4 mi

Marguerite Compton is a Dermatologist in Lake Geneva, Wisconsin. Dr. Compton and is rated as an Advanced provider by MediFind in the treatment of Seborrheic Keratosis. Her top areas of expertise are Actinic Keratosis, Warts, Psoriasis, and Seborrheic Keratosis.

351 S Greenleaf Ave E, 
Park City, IL 
 33.2 mi
Accepting New Patients
Offers Telehealth

Kavitha Gandhi is a Dermatologist in Park City, Illinois. Dr. Gandhi and is rated as an Advanced provider by MediFind in the treatment of Seborrheic Keratosis. Her top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Stiff Skin Syndrome. Dr. Gandhi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dermatology
Dermatology

Aurora Medical Group, Inc.

1575 N Rivercenter Dr, 
Milwaukee, WI 
 41.4 mi

Atif Ahmed is a Dermatologist in Milwaukee, Wisconsin. Dr. Ahmed has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Seborrheic Keratosis. His top areas of expertise are Actinic Keratosis, Bowen's Disease, Epidermodysplasia Verruciformis, and Warts.

What is the outlook (prognosis) for Seborrheic Keratosis?

Removing the growths is simple and generally does not cause scars. You may have patches of lighter skin where growths on the torso have been removed.

Growths usually do not return after they are removed. You may develop more growths in the future if you are prone to the condition.

What are the possible complications of Seborrheic Keratosis?

These complications may occur:

  • Irritation, bleeding, or discomfort of growths
  • Mistake in diagnosis (growths may look like skin cancer tumors)
  • Distress due to physical appearance
When should I contact a medical professional for Seborrheic Keratosis?

Contact your provider if you have symptoms of seborrheic keratosis.

Also contact if you have new symptoms, such as:

  • A change in the appearance of the skin growth
  • New growths
  • A growth that looks like seborrheic keratosis, but occurs by itself or has ragged borders and irregular color. Your provider will need to examine it for skin cancer.
What are the latest Seborrheic Keratosis Clinical Trials?
Open-Label Study of the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ)

Summary: Open-Label study evaluating safety and efficacy of SM-020 Gel 1.0% in subjects with Seborrheic Keratoses and Non-Melanoma Skin Cancers (i.e. Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ). Subjects will be enrolled into 1 of 5 cohorts. Each cohort will enroll approximately 5-10 subjects with at least 1 eligible lesion to be treated. A maximum of 5 lesions may be enrolled per subject. Tr...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized Double-Blind Vehicle-Controlled Study of the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

Summary: The objective of the trial is to evaluate the safety and efficacy of SM-020 gel 1.0% in subjects with Seborrheic Keratosis (SK) compared to vehicle gel. It is a randomized, double-blind, vehicle-controlled trial. Approximately 60 subjects will be enrolled. Subjects will apply their assigned investigational product twice daily for 4 consecutive weeks. Subjects will be followed for 12-weeks post fin...

Who are the sources who wrote this article ?

Published Date: November 18, 2022
Published By: Elika Hoss, MD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Fitzpatrick JE, High WA, Kyle WL. Papillomatous and verrucous lesions. In: Fitzpatrick JE, High WA, Kyle WL, eds. Urgent Care Dermatology: Symptom-Based Diagnosis. Philadelphia, PA: Elsevier; 2018:chap 28.

James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Epidermal nevi, neoplasms, and cysts. In: James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM, eds. Andrews' Diseases of the Skin: Clinical Dermatology. 13th ed. Philadelphia, PA: Elsevier; 2020:chap 29.

Marks JG, Miller JJ. Epidermal growths. In: Marks JG, Miller JJ, eds. Lookingbill and Marks' Principles of Dermatology. 6th ed. Philadelphia, PA: Elsevier; 2019:chap 5.

Patterson JW. Tumors of the epidermis. In: Patterson JW, ed. Weedon's Skin Pathology. 5th ed. Philadelphia, PA: Elsevier Limited; 2021:chap 32.

Requena L, Requena C, Cockerell CJ. Benign epidermal tumors and proliferations. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia, PA: Elsevier; 2018:chap 109.